Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety
MT Mascellino, F Di Timoteo… - Infection and drug …, 2021 - Taylor & Francis
This review takes into consideration the principal vaccines developed against the SARS-
CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of …
CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of …
Review of current COVID-19 diagnostics and opportunities for further development
Y Mardian, H Kosasih, M Karyana, A Neal… - Frontiers in …, 2021 - frontiersin.org
Diagnostic testing plays a critical role in addressing the coronavirus disease 2019 (COVID-
19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV …
19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV …
The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
Understanding how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged in 2019 is critical to preventing future zoonotic outbreaks before they become the …
emerged in 2019 is critical to preventing future zoonotic outbreaks before they become the …
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
L Guo, G Wang, Y Wang, Q Zhang, L Ren, X Gu… - The Lancet …, 2022 - thelancet.com
Background The memory immune response is crucial for preventing reinfection or reducing
disease severity. However, the robustness and functionality of the humoral and T-cell …
disease severity. However, the robustness and functionality of the humoral and T-cell …
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
European governments use non-pharmaceutical interventions (NPIs) to control resurging
waves of COVID-19. However, they only have outdated estimates for how effective individual …
waves of COVID-19. However, they only have outdated estimates for how effective individual …
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
C Feng, J Shi, Q Fan, Y Wang, H Huang, F Chen… - Nature …, 2021 - nature.com
SARS-CoV-2 vaccination has been launched worldwide to build effective population-level
immunity to curb the spread of this virus. The effectiveness and duration of protective …
immunity to curb the spread of this virus. The effectiveness and duration of protective …
COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries
Background The availability of various types of COVID-19 vaccines and diverse
characteristics of the vaccines present a dilemma in vaccination choices, which may result in …
characteristics of the vaccines present a dilemma in vaccination choices, which may result in …
Examining vaccine hesitancy in Sub-Saharan Africa: a survey of the knowledge and attitudes among adults to receive COVID-19 vaccines in Ghana
T Acheampong, EA Akorsikumah, J Osae-Kwapong… - Vaccines, 2021 - mdpi.com
The impact of COVID-19 vaccination programmes on disease transmission, morbidity and
mortality relies heavily on the population's willingness to accept the vaccine. We explore …
mortality relies heavily on the population's willingness to accept the vaccine. We explore …
Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR …
D Michlmayr, CH Hansen, SM Gubbels… - The Lancet Regional …, 2022 - thelancet.com
Background The level of protection after a SARS-CoV-2 infection against reinfection and
COVID-19 disease remains important with much of the world still unvaccinated. Methods …
COVID-19 disease remains important with much of the world still unvaccinated. Methods …
The way of SARS-CoV-2 vaccine development: success and challenges
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2 …
coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2 …